[1]
Borg J, Papadopoulos P, Georgitsi M, et al. (2010); Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet 2010 42(9): 801-5.
[2]
Giardine B, Borg J, Higgs DR, et al. Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach. Nat Genet 2011; 43(4): 295-301.
[3]
Sosnay PR, Siklosi KR, Van Goor F, et al. Defining the disease-liability of mutations in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet 2013; 45(10): 1160-7.
[4]
Mizzi C, Mitropoulou C, Mitropoulos K, et al. Personalized pharmacogenomics profiling using whole genome sequencing. Pharmacogenomics 2014; 15(9): 1223-34.
[5]
van Baal S, Kaimakis P, Phommarinh M, et al. FINDbase: A relational database recording frequencies of genetic defects leading to inherited disorders worldwide. Nucleic Acids Res 2007; 35(Database issue): D690-5.
[6]
Georgitsi M, Viennas E, Gkantouna V, et al. FINDbase: A worldwide database for genetic variation allele frequencies updated. Nucleic Acids Res 2011; 39(Database issue): D926-32.
[7]
Papadopoulos P, Viennas E, Gkantouna V, et al. Developments in FINDbase worldwide database for clinically relevant genomic variation allele frequencies. Nucleic Acids Res 2014; 42(Database issue): D1020-6.
[8]
Viennas E, Komianou A, Mizzi C, et al. Expanded national database collection and data coverage in the FINDbase worldwide database for clinically relevant genomic variation allele frequencies. Nucleic Acids Res 2017; 45(D1): D846-53.
[9]
Mitropoulou C, Fragoulakis V, Rakicevic LB, et al. Economic analysis of pharmacogenomic-guided clopidogrel treatment in Serbian patients with myocardial infarction undergoing primary percutaneous coronary intervention. Pharmacogenomics 2016; 17(16): 1775-84.
[10]
Mitropoulou C, Fragoulakis V, Bozina N, et al. Economic evaluation for pharmacogenomic-guided warfarin treatment for elderly Croatian patients with atrial fibrillation. Pharmacogenomics 2015; 16(2): 137-48.
[11]
Fragoulakis V, Bartsakoulia M, Díaz-Villamarín X, et al. Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention. J Pharmacogenomics 2019; 19: 438-44.
[12]
Fragoulakis V, Roncato R, Fratte CD, et al. Estimating the effectiveness of DPYD genotyping in Italian individuals suffering from cancer based on the cost of chemotherapy-induced toxicity. Am J Hum Genet 2019; 104(6): 1158-68.
[13]
Patrinos GP, Ansorge W. Molecular diagnostics Elsevier/Academic Press, Burlington, CA, USA, ISBN 0125466617.
[14]
Patrinos GP, Ansorge W. Molecular Diagnostics 2nd ed Elsevier/Academic Press, Burlington, CA, USA, ISBN 0123745373.
[15]
Fragoulakis V, Mitropoulou C, Williams MS, Patrinos GP. Economic evaluation in genomic medicine Elsevier/Academic Press,
Burlington, CA, USA, ISBN 978-0128014974.
[16]
Patrinos GP, Danielson P, Ansorge W. Molecular diagnostics 3rd ed Elsevier/Academic Press, Burlington, CA, USA ISBN 978-
0128029718.
Related Books
Industrial Applications of Soil Microbes
Industrial Applications of Soil Microbes
Algal Biotechnology for Fuel Applications
Omics Technologies for Clinical Diagnosis and Gene Therapy: Medical Applications in Human Genetics
Biopolymers Towards Green and Sustainable Development
Environmental Microbiology: Advanced Research and Multidisciplinary Applications
Biomarkers in Medicine
Industrial Applications of Soil Microbes
Sustainable Utilization of Fungi in Agriculture and Industry
Myconanotechnology: Green Chemistry for Sustainable Development
Article Metrics
20
2
1
1